| |
PRODUCT NAME |
ORDER |
 |
2-Pyridinecarboxaldehyde, 6-methoxy-5-methyl- (9CI) |
 |
 |
2-Pyridinecarboxaldehyde, 6-methoxy-3-methyl- (9CI) |
 |
 |
Cyclopropanecarboxaldehyde, 1-(1,2,3-trihydroxypropyl)-, [R-(R*,S*)]- (9CI) |
 |
 |
Bicyclo[2.2.2]oct-5-ene-2-carboxaldehyde, 2-methyl-, (1R,2S,4R)-rel- (9CI) |
 |
 |
Bicyclo[2.2.2]oct-5-ene-2-carboxaldehyde, 2-methyl-, (1R,2R,4R)-rel- (9CI) |
 |
 |
1-Piperazinecarboxylicacid,4-methyl-,2-propynylester(9CI) |
 |
 |
1-Pyrrolidinecarboxylicacid,2-propynylester(9CI) |
 |
 |
2-Hydroxy-N,N,N,N,,N,,N,-hexamethyl-1,3-propane diaminium diiodide |
 |
 |
1H-Pyrrole-2-carbonitrile,4-ethyl-1-methyl-(9CI) |
 |
 |
2-Pyridinecarbonyl chloride, 5-ethyl- (9CI) |
 |
 |
5,6-difluoro-1H-benzimidazole-2-thiol |
 |
 |
Thiazole, 4-(1H-pyrazol-1-yl)- |
 |
 |
Thiazole, 2-(1H-pyrazol-1-yl)- |
 |
 |
4-(MALEINIMIDO)PHENYL ISOCYANATE* |
 |
 |
1H-Imidazole-5-carbonyl chloride, 1-propyl- (9CI) |
 |
 |
1H-Imidazole-5-carbonyl chloride, 1-butyl- (9CI) |
 |
 |
1H-Imidazole-5-carboxylicacid,1-butyl-(9CI) |
 |
 |
Prulifloxacin |
 |
 |
1-AMINO-2,2-DIMETHYLCYCLOPROPANECARBOXYLIC ACID |
 |
 |
Pyrrolidine, 2-(1-methylethyl)-1-(1-oxo-2-propenyl)-, (S)- (9CI) |
 |
 |
(3S)-3-Methyl-4-(tert-buty)diphenylsilyloxy)butanal |
 |
 |
Pyrido[1,2-a]benzimidazol-8-ol (9CI) |
 |
 |
Platinum tetrammine hydrogencarbonate |
 |
 |
Imidazo[1,2-a]pyrazin-3(7H)-one, 6-(3-hydroxyphenyl)-2-[(4-hydroxyphenyl)methyl]-8-(phenylmethyl)- |
 |
 |
Imidazo[1,2-a]pyrazin-3(7H)-one, 6-(4-fluorophenyl)-2-[(4-hydroxyphenyl)methyl]-8-(phenylmethyl)- |
 |
 |
Imidazo[1,2-a]pyrazin-3(7H)-one, 6-(4-hydroxyphenyl)-2-[(4-hydroxyphenyl)methyl]-5-methyl-8-(phenylmethyl)- |
 |
 |
Imidazo[1,2-a]pyrazin-3(7H)-one, 6-(4-hydroxyphenyl)-2-[(4-hydroxyphenyl)methyl]-8-(2-methylpropyl)- |
 |
 |
Propanoic acid, 2-(2-benzothiazolyl)hydrazide (9CI) |
 |
 |
Nalpha-Cbz-L-Arginine |
 |
 |
1,7-Naphthyridin-5-amine(9CI) |
 |
 |
1,-(cyclopropylmethyl)-5,-iodospiro[[1,3]dioxane-2,3,-indolin]-2,-one |
 |
 |
SULFOACETIC ACID |
 |
 |
4(1H)-Pyrimidinone, 2-hydroxy-5-methyl- (9CI) |
 |
 |
4-Hydroxy-4-methyl-2-pentanone |
 |
 |
2-Pentanone, 4-amino-1,1,1-trifluoro- |
 |
 |
3-Thiophenecarboxylicacid,4-[(aminosulfonyl)amino]-,methylester(9CI) |
 |
 |
2-Propanone, 1-(2-morpholinyl)- (9CI) |
 |
 |
3-Trifluoromethylthio-phenyl-hydrazine |
 |
 |
4,5-dichlorothiophene-3-carboxylic acid |
 |
 |
Boc-L-glutamic acid 5-fluorenylmethylester |
 |
 |
Cyclopentanecarboxylic acid, 3,4-dihydroxy-, methyl ester, (1alpha,3beta,4beta)- (9CI) |
 |
 |
2-Oxazolidinone,4-(1-methylethyl)-5-(2-propenyl)-,(4S-trans)-(9CI) |
 |
 |
2-Oxazolidinone,4-(1-methylethyl)-5-(2-propenyl)-,(4S-cis)-(9CI) |
 |
 |
CHOLINE HYDROXIDE; (48-50% AQUOUOS SOLUTION) |
 |
 |
1-Azabicyclo[3.2.0]heptane-2-carboxylicacid,7-oxo-,(2S,5S)-(9CI) |
 |
 |
1-Azabicyclo[3.2.0]heptane-2-carboxylicacid,7-oxo-,methylester,(2R,5R)-(9CI) |
 |
 |
erythro-Pentaric acid, 3-deoxy-, 1,4-lactone (9CI) |
 |
 |
Ethanone, 1-[4-(2-propynyl)-1-cyclohexen-1-yl]- (9CI) |
 |
 |
3-Nonen-8-yn-2-one, (3E)- (9CI) |
 |
 |
4-Nonen-8-yn-2-one, (E)- (9CI) |
 |